Skip to content
Loading...

New breakthrough in advanced HCC

Digital Liver Cancer Summit 2021: New follow-up data from a landmark study of liver cancer patients treated with a combination of atezolizumab and bevacizumab has shown the longest ever survival time in a frontline phase 3 trial of systemic therapy…

Read more

Looking towards bright horizons for 2021

This year has been unlike any other. COVID-19 brought unimaginable challenges to the medical community, placing you at the forefront of the pandemic. The year 2020 posed unique questions to those of us treating liver patients and focusing on liver diseases. …

Read more

Call for nominations for two new Scientific Committee members to join the EASL Governing Board

Are you deeply engaged in both hepatology and science and ready to get involved in EASL’s governance?    EASL is now calling for nomination of two new Scientific Committee members to join the Governing Board. The term for these members is from the International Liver Congress (ILC) 2021 (end-June 2021) to ILC 2024.   Please note: …

Read more
Back To Top